Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 10
Abstract
Viral infections emerge in the pathogenesis of subacute thyroiditis. Aside from this, subacute thyroiditis following vaccines utilizing inactivated viruses has been shown on rare occasions. Due to the COVID-19 pandemic, several vaccines have been developed all over the world; mass and unprecedented vaccination has thus been initiated. However, it is known that cases such as subacute thyroiditis have been reported, albeit rarely, after administration of COVID-19 vaccines. In this case report, we present a 59-year-old patient with multiple myeloma developing subacute thyroiditis following BNT162b2 vaccine. Patient had swelling in the neck, and his symptoms were controlled with non-steroidal anti-inflammatory drugs. Subacute thyroiditis following administration of the COVID-19 vaccine is rare; however, it is likely an under-reported condition that is difficult to detect. Clinicians should stay informed and have increased awareness of post-COVID-19 vaccine subacute thyroiditis.Keywords
This publication has 41 references indexed in Scilit:
- Subacute thyroiditis following seasonal influenza vaccinationHuman Vaccines & Immunotherapeutics, 2016
- Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapyBritish Journal of Haematology, 2015
- International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaThe Lancet Oncology, 2014
- Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patientsHaematologica, 2014
- De Quervain thyroiditis in the course of H1N1 influenza infection.2014
- Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myelomaBlood, 2012
- Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trialLeukemia, 2009
- Thyroiditis: Acute, Subacute, and ChronicMedical Clinics of North America, 1991
- High prevalence of subacute thyroiditis during summer season in ItalyJournal of Endocrinological Investigation, 1987
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981